Disturbed dream sleep may indicate later Parkinson's disease.

The ATMP-GMPDU development unit at the Institute for Cell Therapeutics supports research groups in the development of new cellular drugs.

A clinical trial under MHH leadership is testing a new therapy with immune cells against the JC virus.

Chronic fatigue syndrome (CFS) is a heavy burden. The "EXTINCT post COVID" project is investigating the effectiveness of apheresis therapy and is…

The MHH is participating in the EU project PIECES and aims to reduce the risk of cancer and improve liver health with personalized exercise programs.

The bacterium Haemophilus influenzae type b (Hib) can cause severe meningitis in young children. Our researchers now have a way to make the Hib…

MHH Cardiology participates in a nationwide project to improve risk assessment thanks to structured and standardized data.

A clinical trial will investigate the drug's efficacy in dementia patients.

Research team of the MHH and the Cluster of Excellence RESIST clarify cell mechanism. The result is the basis for new therapies.

Feature combination of Siglec-16 and polysialic acid increases survival in patients with glioblastoma